A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants have risen to dominance, which contains far more mutations in the spike protein in comparison to previously reported variants, compromising the efficacy of most existing vaccines or therapeutic monoclonal a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yuying, Li, Qianlin, Fan, Huahao, Liao, Conghui, Zhang, Jingsong, Hu, Huan, Yi, Huaimin, Peng, Yuanli, Lu, Jiahai, Chen, Zeliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869787/
https://www.ncbi.nlm.nih.gov/pubmed/36700149
http://dx.doi.org/10.2147/IJN.S387160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869787/
https://www.ncbi.nlm.nih.gov/pubmed/36700149
http://dx.doi.org/10.2147/IJN.S387160

Ejemplares similares